Skip to main content
Rosemont Pharmaceuticals

Rosemont Pharmaceuticals Rating A · Worker

Rosemont Pharmaceuticals is a specialist manufacturer of prescription oral liquid medicines developed for patients who have swallowing difficulties.

Rosemont Pharmaceuticals Limited Healthcare Leeds Website ↗

The UK Home Office lists Rosemont Pharmaceuticals as a licensed sponsor (A-rated, Skilled Worker route). They can sponsor work visas. We read every advert and list only roles that don't rule out sponsorship. Home Office figures released under the Freedom of Information Act show Rosemont Pharmaceuticals assigned 17 Certificates of Sponsorship in 2021–24 for Skilled Worker and Global Business Mobility visas. We're showing 3 of their current openings.

Sponsor licence details

Sourced from the UK Home Office register of licensed sponsors.

Licence rating
A
Worker · Active
Visa sponsorships
17
2021–24 · Home Office
Licensed
Since at least 2021
Headcount
51-200
193 total
Open roles
3
Live on SponsorJobs
Sector
Healthcare
Location
Leeds
Visa route
Skilled Worker

Sponsorship history

Certificates of Sponsorship Rosemont Pharmaceuticals assigned each year, from Home Office figures released under the Freedom of Information Act.

2021
1–5
2022
1–5
2023
1–5
2024
1–5
2025
—

Skilled Worker and Global Business Mobility routes. One certificate is assigned for each sponsored hire, visa extension or change of employer, so a person can be counted more than once. “1–5” is withheld by the Home Office; the 2025 figures list only sponsors with 5 or more (“—”). Matched to this employer by its name on the sponsor register. Sources: FOI 2025/12841 (2021–24), FOI2026/03501 (2025). Contains public sector information licensed under the Open Government Licence v3.0.

About Rosemont Pharmaceuticals

Rosemont Pharmaceuticals is a global pharmaceutical company that specialises in the development, manufacture, and supply of prescription oral liquid medicines. With nearly 60 years of experience, the company focuses on providing liquid medicine solutions for patients with dysphagia, a condition common among stroke, dementia, and head and neck cancer patients.

The company operates research and development facilities alongside a dedicated manufacturing plant. Its scientific teams develop liquid alternatives to traditional solid-dose medications, serving healthcare professionals and patients across more than 40 international markets.

Open roles

3 live positions matched to this sponsor licence.